Proposed legislation could impact cosmetic packaging

Following FDA's recent push to monitor health claims on functional foods this proposal calls for full disclosure of ingredients, reporting of adverse health effects and random testing for pathogens or contaminants.

Hp 19437 Lipstickkiss1
According to the article on website Eye On FDA , members of congress Jan Schakowsky (D-IL), Ed Markey (D-MA) and Tammy Baldwin (D-WI) have proposed The Safe Cosmetics Act of 2010 (H.R.5786). This sweeping proposal would give the FDA new authority to regulate everything from lotions and lipsticks to deodorants and fragrances.

The $50 billion cosmetics industry, one of the least regulated markets, uses roughly 12,500 unique chemical ingredients in personal care products—the vast majority of which have never been assessed for safety by any publicly accountable body, says Eye on FDA.

Key provisions include:

• Ingredient testing and safety restrictions (including banning harmful substances)
• Ingredient Labels on Cosmetics
• Post Market Testing (random sample testing for pathogens or contaminants)
• Market restrictions (voluntary recalls and power to halt distribution)
• Submission of list of ingredients to the FDA, including perfume
• Mandatory adverse health effect reporting

For packaging designers, the label on each package of cosmetics would be required to list the name of each ingredient, including the components of a fragrance--which I believe can include hundreds of ingredients! Quite the labeling dilemma…

Get your daily dose of global packaging news, follow me on Twitter .
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?